- Home
- SMTK vs ADGM Comparison
SMTK vs ADGM Comparison
Compare SMTK & ADGM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMTK
- ADGM
- Stock Information
- Founded
- SMTK 2009
- ADGM 2011
- Country
- SMTK United Kingdom
- ADGM United States
- Employees
- SMTK N/A
- ADGM N/A
- Industry
- SMTK
- ADGM
- Sector
- SMTK
- ADGM
- Exchange
- SMTK NYSE
- ADGM NYSE
- Market Cap
- SMTK 13.3M
- ADGM 12.7M
- IPO Year
- SMTK N/A
- ADGM N/A
- Fundamental
- Price
- SMTK $3.72
- ADGM $0.77
- Analyst Decision
- SMTK
- ADGM
- Analyst Count
- SMTK 0
- ADGM 0
- Target Price
- SMTK N/A
- ADGM N/A
- AVG Volume (30 Days)
- SMTK 109.9K
- ADGM 1.2M
- Earning Date
- SMTK 02-12-2025
- ADGM 02-15-2025
- Dividend Yield
- SMTK N/A
- ADGM N/A
- EPS Growth
- SMTK N/A
- ADGM N/A
- EPS
- SMTK N/A
- ADGM N/A
- Revenue
- SMTK $40,000.00
- ADGM $543,000.00
- Revenue This Year
- SMTK N/A
- ADGM N/A
- Revenue Next Year
- SMTK N/A
- ADGM N/A
- P/E Ratio
- SMTK N/A
- ADGM N/A
- Revenue Growth
- SMTK 471.43
- ADGM 187.30
- 52 Week Low
- SMTK $2.01
- ADGM $0.75
- 52 Week High
- SMTK $13.00
- ADGM $9.34
- Technical
- Relative Strength Index (RSI)
- SMTK N/A
- ADGM N/A
- Support Level
- SMTK N/A
- ADGM N/A
- Resistance Level
- SMTK N/A
- ADGM N/A
- Average True Range (ATR)
- SMTK 0.00
- ADGM 0.00
- MACD
- SMTK 0.00
- ADGM 0.00
- Stochastic Oscillator
- SMTK 0.00
- ADGM 0.00
About SMTK SMARTKEM INC
SmartKem Inc focuses on the design, development, industrialization, and technology transfer of low-temperature, solution-deposited organic semiconductors for transistor backplanes. The company's semiconductor platform can be used in a number of applications including mini-LED displays, AMOLED displays, fingerprint sensors, and logic circuits. The company derives revenue from the sale of TRUFLEX inks and demonstration products.
About ADGM ADAGIO MEDICAL HOLDINGS INC
Adagio Medical Holdings Inc is an innovator in catheter ablation technologies for treatment of cardiac arrhythmias. The company focuses on developing innovative cryoablation technologies that create contiguous, transmural lesions to treat cardiac arrhythmias, including paroxysmal and persistent atrial fibrillation, atrial flutter, and ventricular tachycardia.